Primary |
Drug Use For Unknown Indication |
30.7% |
Pain |
20.4% |
Product Used For Unknown Indication |
19.8% |
Back Pain |
6.9% |
Drug Abuser |
5.9% |
Drug Abuse |
4.1% |
Breakthrough Pain |
2.2% |
Cancer Pain |
1.5% |
Hypertension |
1.2% |
Depression |
0.9% |
Arthralgia |
0.9% |
Neck Pain |
0.8% |
Insomnia |
0.8% |
Analgesic Therapy |
0.7% |
Anxiety |
0.6% |
Fibromyalgia |
0.6% |
Diabetes Mellitus |
0.5% |
Pain In Extremity |
0.5% |
Neuralgia |
0.5% |
Procedural Pain |
0.5% |
|
Death |
13.4% |
Drug Dependence |
11.6% |
Vomiting |
11.4% |
Suicidal Ideation |
9.1% |
Substance Abuse |
8.3% |
Overdose |
6.4% |
Pain |
4.6% |
Drug Abuser |
4.3% |
Weight Decreased |
4.2% |
Suicide Attempt |
3.3% |
Drug Abuse |
2.9% |
Product Formulation Issue |
2.7% |
Tremor |
2.6% |
Somnolence |
2.5% |
Withdrawal Syndrome |
2.5% |
Myocardial Infarction |
2.1% |
Unevaluable Event |
2.1% |
Road Traffic Accident |
2.1% |
Hospitalisation |
1.9% |
Intentional Drug Misuse |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
25.1% |
Pain |
19.6% |
Drug Use For Unknown Indication |
11.3% |
Back Pain |
6.9% |
Arthralgia |
5.7% |
Cancer Pain |
4.4% |
Breakthrough Pain |
3.9% |
Hypertension |
3.1% |
Prophylaxis |
2.6% |
Depression |
2.2% |
Insomnia |
2.2% |
Constipation |
2.2% |
Pain In Extremity |
2.0% |
Anxiety |
1.8% |
Analgesic Therapy |
1.7% |
Diabetes Mellitus |
1.1% |
Neck Pain |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Drug Abuse |
1.0% |
Neuralgia |
1.0% |
|
Vomiting |
19.0% |
Somnolence |
10.1% |
Overdose |
6.4% |
Pain |
5.7% |
Death |
5.6% |
Drug Dependence |
5.6% |
Weight Decreased |
5.1% |
Suicidal Ideation |
4.5% |
Suicide Attempt |
3.9% |
Nausea |
3.4% |
Drug Ineffective |
3.3% |
Substance Abuse |
3.3% |
Wrong Technique In Drug Usage Process |
3.3% |
Toxicity To Various Agents |
3.1% |
Urinary Retention |
3.1% |
Vision Blurred |
3.1% |
Withdrawal Syndrome |
3.0% |
Drug Hypersensitivity |
2.8% |
Drug Abuse |
2.7% |
Malaise |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
19.8% |
Pain |
14.3% |
Drug Use For Unknown Indication |
11.4% |
Prophylaxis |
8.5% |
Multiple Myeloma |
6.4% |
Cancer Pain |
4.6% |
Hypertension |
4.0% |
Constipation |
3.5% |
Depression |
3.2% |
Back Pain |
3.1% |
Rheumatoid Arthritis |
2.6% |
Breast Cancer |
2.5% |
Nausea |
2.4% |
Non-small Cell Lung Cancer |
2.3% |
Metastases To Bone |
2.2% |
Insomnia |
1.9% |
Osteoporosis |
1.9% |
Metastatic Renal Cell Carcinoma |
1.8% |
Plasma Cell Myeloma |
1.8% |
Renal Cell Carcinoma |
1.8% |
|
Vomiting |
17.1% |
Weight Decreased |
10.3% |
White Blood Cell Count Decreased |
6.7% |
Death |
5.9% |
Weight Increased |
5.8% |
Pain |
5.8% |
Pneumonia |
5.4% |
Pyrexia |
4.9% |
Thrombocytopenia |
4.1% |
Nausea |
4.0% |
Urinary Tract Infection |
3.7% |
Pulmonary Embolism |
3.3% |
Sepsis |
3.1% |
Renal Failure Acute |
3.0% |
Rash |
2.9% |
Vision Blurred |
2.9% |
Interstitial Lung Disease |
2.8% |
Somnolence |
2.8% |
Stomatitis |
2.8% |
Drug Ineffective |
2.7% |
|
Interacting |
Pain |
16.8% |
Drug Use For Unknown Indication |
10.0% |
Product Used For Unknown Indication |
8.8% |
Depression |
8.5% |
Arthralgia |
5.3% |
Arthritis |
5.0% |
Smoking Cessation Therapy |
5.0% |
Asthma |
4.5% |
Postoperative Analgesia |
4.5% |
Hypertension |
4.0% |
Drug Abuse |
3.8% |
Neuralgia |
3.8% |
Pneumonia |
3.3% |
Sarcoidosis |
3.0% |
Bladder Disorder |
2.5% |
Blood Cholesterol Increased |
2.5% |
Mineral Supplementation |
2.5% |
Oral Candidiasis |
2.3% |
Thyroid Disorder |
2.3% |
Gout |
2.0% |
|
Urinary Retention |
16.1% |
Drug Interaction |
11.5% |
Weight Increased |
11.5% |
Myoclonus |
10.3% |
Somnolence |
8.0% |
Weight Decreased |
4.6% |
Pain |
3.4% |
Respiratory Arrest |
3.4% |
Respiratory Depression |
3.4% |
Unevaluable Event |
3.4% |
Withdrawal Syndrome |
3.4% |
Anxiety |
2.3% |
Multiple Drug Overdose Intentional |
2.3% |
Potentiating Drug Interaction |
2.3% |
Product Size Issue |
2.3% |
Renal Failure Acute |
2.3% |
Speech Disorder |
2.3% |
Stupor |
2.3% |
Substance Abuse |
2.3% |
Swollen Tongue |
2.3% |
|